Viewing nowWiemethan Tablet 20mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

MFDS item code 201100917 · Approved 2011.02.24 · Insurance code 660702450
Treatment of essential hypertension
Used to treat essential hypertension, focusing on controlling blood pressure within the normal range to reduce the risk of cardiovascular complications and prevent comorbidities.
<Adults> The recommended initial dose is 10mg once daily, taken with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect reached after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be given in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), treatment should preferably be initiated at a low dose, with their condition monitored closely. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn in the second and third trimesters of pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any ingredients in this medication, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, severe liver dysfunction, bile duct obstruction, and those with genetic issues such as lactose intolerance should not take this medication. Patients with reduced blood volume or salt levels may experience excessively low blood pressure during the initial phase of treatment; thus, their condition needs careful monitoring before and after starting the treatment. This medication may affect kidney function; therefore, patients with impaired kidney function or kidney transplant recipients should have their kidney status and potassium levels regularly checked through blood tests. Patients with kidney vascular issues, those at risk of hyperkalemia, patients with heart valve disease, and those with primary aldosteronism should use this medication with special caution. This drug lowers blood pressure, which may cause dizziness; caution should be exercised when driving or operating hazardous machinery. Some patients may experience mild and transient side effects such as dizziness, headaches, abdominal pain, muscle pain, and rashes. Rarely, angioedema or severe allergic reactions may occur, and if symptoms worsen, immediate medical attention is required. Long-term use of this medication may cause gastrointestinal issues such as chronic diarrhea or malabsorption; hence, if persistent diarrhea or weight loss occurs, the medication should be stopped and consultation with a physician is recommended. Taking potassium-sparing diuretics or potassium supplements together can dangerously elevate blood potassium levels, thus potassium levels should be closely monitored via blood tests when using such medications concurrently. Moreover, concomitant use with lithium or certain nonsteroidal anti-inflammatory drugs may increase the risk of side effects, so it is essential to consult a healthcare provider when taking other medications. Taking this medication during pregnancy can pose a serious risk to the fetus; thus, women planning a pregnancy or who are pregnant should not take this medication and must discontinue it immediately upon confirmation of pregnancy. Women who are breastfeeding should also avoid this medication as it may be passed into breast milk and affect the infant; cessation of breastfeeding or stopping this medication is recommended. Safety and efficacy in pediatric patients have not been established; therefore, it is advisable not to use this medication in children. Elderly patients should use this medication with caution as drug concentration may increase in their bodies; regular monitoring of blood pressure and kidney function is crucial. In case of overdose, excessively low blood pressure or heart rhythm abnormalities may occur; immediate medical attention should be sought if such symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is best to store it at room temperature between 1 degree and 25 degrees Celsius. Proper storage can help maintain the drug's effectiveness for a longer duration.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.